Cygenica
2 known investors
Find your way into Cygenica
Sign up to see every warm intro you have to Cygenica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cygenica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CyGenica develops a targeted intracellular drug delivery technology, the GEENIE platform, to deliver therapeutic molecules into cells more safely and efficiently. Its work focuses on treatments for oncology and rare genetic diseases, serving biopharmaceutical companies developing therapies.
Investors · 2
Frequently asked questions
- What does Cygenica do?
- CyGenica develops a targeted intracellular drug delivery technology, the GEENIE platform, to deliver therapeutic molecules into cells more safely and efficiently. Its work focuses on treatments for oncology and rare genetic diseases, serving biopharmaceutical companies developing therapies.
- Who are Cygenica's investors?
- Cygenica's investors include Golden Sparrow Ventures, Llc, SOSV.
